Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Platelet Disorders and Treatments

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on platelet disorders, thrombosis mechanisms, and related conditions such as immune thrombocytopenic purpura and von Willebrand disease. It covers topics including platelet function, hemostasis, inflammation, megakaryocyte development, and the molecular mechanisms underlying thrombus formation.

300
Works

How has Platelet Disorders and Treatments's publication output changed over time?

ScholarIQpublication output · 1997–2019

Output grew100% over the shown period — from 1 works in 1997 to 2 in 2019.

1
1
1
1
1
1
1
1
2
2
1997199820022003200620072010201420182019

What are the most-cited papers on Platelet Disorders and Treatments?

ScholarIQmost cited works
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert, Deirdra R. Terrell, Donald M. Arnold, George R. Buchanan, Douglas B. Cines, Nichola Cooper, Adam Cuker, Jenny M. Despotovic, James N. George, Rachael F. Grace, Thomas Kühne, David J. Kuter, Wendy Lim, Keith R. McCrae, Barbara Pruitt, Hayley Shimanek, Sara K. Vesely
Blood Advances. 20191,360 CitationsOPEN ACCESS
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Éric Boilard, Peter A. Nigrović, Katherine Larabee, Gerald F. Watts, Jonathan S. Coblyn, Michael E. Weinblatt, Elena Massarotti, Eileen Remold‐O’Donnell, Richard W. Farndale, Jerry Ware, David Lee
Science. 20101,074 Citations
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Yuqing Huo, Andreas Schober, S. Bradley Forlow, David F. Smith, Matthew C. Hyman, Steffen Jung, Dan R. Littman, Christian Weber, Klaus Ley
Nature Medicine. 20021,002 Citations
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
James B. Bussel, Donald M. Arnold, Elliot Grossbard, Jiřı́ Mayer, Jacek Treliński, Wojciech Homenda, Andrzej Hellmann, Jerzy Windyga, Liliya Sivcheva, Alhossain A. Khalafallah, Francesco Zaja, Nichola Cooper, Vadim Markovtsov, Hany Zayed, Anne‐Marie Duliège
American Journal of Hematology. 2018359 CitationsOPEN ACCESS
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review
Cindy Neunert, Nastaran Noroozi, Geoff Norman, George R. Buchanan, Jennifer Goy, Ishac Nazi, John G. Kelton, Donald M. Arnold
S164469042. 2014340 CitationsOPEN ACCESS

Where is Platelet Disorders and Treatments research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Platelet Disorders and Treatments is open access?

ScholarIQopen access share
47%OPEN ACCESS
Gold
7%
Green
0%
Hybrid
7%
Bronze
33%
Closed
53%

Related on ScholarIQ

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Paper
Genomic atlas of the human plasma proteome
Paper
Clopidogrel for Coronary Stenting
Paper
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
Paper
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Paper
EULAR recommendations for the management of antiphospholipid syndrome in adults
Paper
470M+ articles · free account